Reversible O 2 -binding and activation have been studied using dicopper and diiron complexes of various hexapyridine ligands as functional models of hemocyanin (Hc) and soluble methane monooxygenase (sMMO), respectively. Dicopper(I) complexes of sterically hindered hexapyridine ligands react with O 2 to form -
:2 -peroxo-dicopper(II) complexes stable at room temperature, which release O 2 to attain reversible O 2 -binding. When a sterically hindered hexapyridine ligand methylated at the bridgehead positions is used, the O 2 -release becomes easier, and reversibility is greatly improved. Detailed structural studies of Cu I and Cu II complexes of sterically hindered tripyridine ligands showed that the bridgehead alkyl group causes a pyridine shift leading to structural modulation of the copper complexes. A hexapyridine ligand can be used to form a thermally stable peroxo-diiron(III) complex, which can oxygenate hydrocarbons upon addition of acid chloride/DMF. Diiron(III) complexes of a bis-tpa type hexapyridine ligand catalyze epoxidation of various alkenes with H 2 O 2 . A peroxo-diiron(III) complex is detected as an intermediate. Detailed isotopelabeling experiments showed that the peroxo intermediate is converted to dioxo--oxo-diiron(IV) complex, and that three oxygen atoms of the active species scramble with each other. Stable dinuclear structure, structural modulation, and structural flexibility, which may be from the hexapyridine ligands, play key roles in reversible O 2 -binding and activation by the dicopper and diiron complexes.